IRIDEX (IRIX) vs ENDRA Life Sciences (NDRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
IRIDEX is the larger company by market cap ($15.4 million vs $9.1 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | IRIX | NDRA |
|---|---|---|
| Share price | $0.8783 | $6.06 |
| Market cap | $15.43M | $9.09M |
| 1-day change | +29.16% | +0.33% |
| YTD return | -22.96% | — |
| 1-year return | -20.87% | — |
| 5-year return | -88.15% | — |
| EPS (TTM) | $-0.20 | $-6.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.65 | $9.85 |
| 52-week low | $0.61 | $2.96 |
| Distance from 52-week high | -46.77% | -38.48% |
| Average volume | 71.08K | 36.48K |
| Shares outstanding | 17.56M | 1.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
IRIX vs NDRA FAQ
Which is bigger, IRIDEX or ENDRA Life Sciences?
IRIDEX (IRIX) is larger, with a market capitalization of $15.43M compared with $9.09M for ENDRA Life Sciences (NDRA).
Are IRIDEX and ENDRA Life Sciences in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.